FOR PEDIATRIC PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
Taltz pediatric PsO dosing1
Taltz dosing for pediatric psoriasis is based on a patient’s weight.
In some cases, the prefilled Taltz syringe 80mg/mL must be adjusted based on weight, and then administered using a new disposable syringe, with the unused portion of Taltz discarded. Be sure to follow the dosing regimen outlined below as well as the instructions below for preparing tailored, weight-based dosing.
Q4W=every 4 weeks
If patients miss a dose, instruct them to receive a dose as soon as they remember, then to receive their next dose at their regularly scheduled time.
SELECT IMPORTANT ADMINISTRATION INFORMATION: PEDIATRIC PSORIASIS
Advise the patient and/or caregiver to read Medication Guide and Instructions for Use before the patient starts using Taltz, and each time the prescription is renewed, as there may be new information they need to know.
Taltz is intended for use under the guidance and supervision of a physician. Adult patients may self-inject or caregivers may give injections of 80 mg Taltz after training in subcutaneous injection technique using the autoinjector or prefilled syringe. Taltz doses of 20 mg or 40 mg must be prepared and administered by a qualified healthcare provider using aseptic technique.
Instructions on Self-Administration for adults: Provide guidance to patients and caregivers on proper subcutaneous injection technique, including aseptic technique, and how to use the autoinjector or prefilled syringe correctly. Caregivers may give injections to pediatric patients weighing more than 50 kg using the autoinjector or prefilled syringe after training and demonstration of proper subcutaneous injection technique.